2021 ICD-10-CM Code C44.61

Basal cell carcinoma of skin of upper limb, including shoulder

Version 2021

Not Valid for Submission

C44.61 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of basal cell carcinoma of skin of upper limb, including shoulder. The code is not specific and is NOT valid for the year 2021 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: Neoplasm, neoplastic skin NOS limb NEC upper basal cell carcinoma .

ICD-10:C44.61
Short Description:Basal cell carcinoma skin/ upper limb, including shoulder
Long Description:Basal cell carcinoma of skin of upper limb, including shoulder

Code Classification

Specific Coding for Basal cell carcinoma skin/ upper limb, including shoulder

Non-specific codes like C44.61 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for basal cell carcinoma skin/ upper limb, including shoulder:

  • BILLABLE CODE - Use C44.611 for Basal cell carcinoma of skin of unspecified upper limb, including shoulder
  • BILLABLE CODE - Use C44.612 for Basal cell carcinoma of skin of right upper limb, including shoulder
  • BILLABLE CODE - Use C44.619 for Basal cell carcinoma of skin of left upper limb, including shoulder

Table of Neoplasms

The code C44.61 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»Neoplasm, neoplastic
  »skin NOS
    »limb NEC
      »upper
        »basal cell carcinoma
C44.61

Information for Patients


Skin Cancer

Skin cancer is the most common form of cancer in the United States. The two most common types are basal cell cancer and squamous cell cancer. They usually form on the head, face, neck, hands, and arms. Another type of skin cancer, melanoma, is more dangerous but less common.

Anyone can get skin cancer, but it is more common in people who

You should have your doctor check any suspicious skin markings and any changes in the way your skin looks. Treatment is more likely to work well when cancer is found early. If not treated, some types of skin cancer cells can spread to other tissues and organs. Treatments include surgery, radiation therapy, chemotherapy, photodynamic therapy (PDT), and biologic therapy. PDT uses a drug and a type of laser light to kill cancer cells. Biologic therapy boosts your body's own ability to fight cancer.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Code History

  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)